In a previous study (B. P. Lockhart, H. Tsiang, P. E. Ceccaldi, and S. Guillemer, Antiviral Chem. Chemother. 2:9-15, 1991), we demonstrated an antiviral effect of the general anesthetic ketamine for rabies virus in neuronal cultures and in rat brain. This report describes an attempt to determine at what level ketamine acts on the rabies virus cycle in rat cortical neuron cultures. Immunofluorescence and [35S]methionine labelling of infected neurons showed that ketamine (1 to 1.5 mM) inhibited viral nucleoprotein and glycoprotein syntheses. Northern (RNA) blots of total RNA from drug-treated neurons, hybridized with 32P-labelled oligonucleotide probes for rabies virus nucleoprotein, matrix protein, and glycoprotein genes, showed a marked reduction (5-to 11-fold) in the levels of rabies virus mRNAs, relative to those in untreated neurons. No significant change in the levels of cellular 13-actin mRNA were detected in ketamine-treated cells.
In a previous study (B. P. Lockhart, H. Tsiang, P. E. Ceccaldi, and S. Guillemer, Antiviral Chem. Chemother. 2:9-15, 1991), we demonstrated an antiviral effect of the general anesthetic ketamine for rabies virus in neuronal cultures and in rat brain. This report describes an attempt to determine at what level ketamine acts on the rabies virus cycle in rat cortical neuron cultures. Immunofluorescence and [35S]methionine labelling of infected neurons showed that ketamine (1 to 1.5 mM) inhibited viral nucleoprotein and glycoprotein syntheses. Northern (RNA) blots of total RNA from drug-treated neurons, hybridized with 32P-labelled oligonucleotide probes for rabies virus nucleoprotein, matrix protein, and glycoprotein genes, showed a marked reduction (5-to 11-fold) in the levels of rabies virus mRNAs, relative to those in untreated neurons. No significant change in the levels of cellular 13-actin mRNA were detected in ketamine-treated cells.
A similar antiviral effect was observed with MK-801; however, no inhibition of rabies virus synthesis was observed with the general anesthetic chloral hydrate. The antiviral effect was not complete; a time-dependent recovery of viral transcription and rabies virus protein synthesis was observed, but no infectious virus was released into the culture supernatant. The lack of any modification of cellular protein or mRNA synthesis by ketamine suggests an antiviral mechanism acting at the level of rabies virus genome transcription.
Rabies virus, a member of the Rhabdoviridae family, contains an unsegmented negative-stranded RNA genome that codes sequentially for five proteins: nucleoprotein N, phosphoprotein M1, matrix protein M2, glycoprotein G, and RNA-dependent RNA polymerase L (29) . The virus is highly neurotropic (38) and produces dramatic clinical symptoms leading invariably to death (12) . Despite widespread and effective vaccination programs, rabies is still believed responsible for up to 20,000 human fatalities per year (35) . The classical postexposure treatment for rabies infection consists of vaccination and, in cases of severe and advanced exposure, vaccination is combined with immunotherapy with either equine or human antirabies immunoglobulins (37) . However, the limited availability of serum, combined with the potential risk of hepatitis B and human immunodeficiency virus contamination from human sera, has restricted its application and partly contributed to failures of postexposure treatment for rabies (2, 6, 36) . It is for these reasons as well as for the lack of efficient anti-rabies virus agents (8, 11 ) that we were prompted to assess alternative potential drugs for effective postexposure treatment for rabies.
We previously showed that the dissociative anesthetic ketamine, a noncompetitive antagonist of the N-methyl-Daspartate (NMDA) receptor, inhibited the production (100-to 1,000-fold) of rabies virus in a dose-dependent manner and that the inhibitory effect was unrelated to any mechanism operating through high-affinity NMDA receptor sites (20) . The antiviral effect was highly selective for the class of noncompetitive NMDA receptor antagonists binding to the phencyclidine site, because other drugs of this class (MK-801 and phencyclidine derivatives) produced similar antiviral effects (32, 34) . In this study, we attempted to determine which step of the rabies virus replicative cycle in neuronal target cells is inhibited by ketamine so that future possible anti-rabies virus strategies may be developed.
MATERIALS AND METHODS
Infection of cells. Cortical neurons prepared from 16-dayold rat embryos as previously described (20) were seeded into 35-or 60-mm poly-L-ornithine-coated petri dishes and maintained in F-10 medium (GIBCO) supplemented with 7.5% fetal calf serum (Boehringer) and 7.5% horse serum (Boehringer). Five-day-old cultures were infected with 106 PFU of fixed, BHK cell-adapted standard challenge rabies virus per ml, prepared as described by Tsiang et al. (33) , for 1 h at 37°C. Unabsorbed virus was removed by washing, and fresh medium with or without drugs was added immediately. Extracellular rabies virus titers were assayed by plaque titration (26) . Ketamine [1,2- Culture supernatants were removed at 24-h intervals and centrifuged at 500 x g for 20 min. The supernatants were then centrifuged at 100,000 x g for 1.5 h, and the pellets were solubilized in electrophoresis sample buffer (17) . Cell extracts were immunoprecipitated with a rabbit anti-rabies virus nucleoprotein antibody as previously described (18) . Samples were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (17) , and gels were stained with Coomassie blue, dried, and exposed to Kodak X-Omat autoradiographic film for 7 to 14 days.
Preparation of oligonucleotide probes. DNA probes for rabies virus negative-stranded RNA were obtained by restriction enzyme cleavage from M13 plasmids containing rabies virus gene inserts as previously described (30) . The N probe contained a PvuII insert (nucleotides 909 to 1041), the M2 probe contained a BamHI insert (nucleotides 2709 to 2881), and the G probe contained anAccl insert (nucleotides 4584 to 4774); numbering is as for the PV strain of rabies virus (30, 31) . The actin probe was prepared from plasmid pBR322 containing a 1.2-kb PstI insert coding for mouse 0-actin as previously described (10).
Northern (RNA) blotting and hybridization of viral RNAs. Extraction of viral RNA from standard challenge rabies virus-infected cortical neurons seeded in petri dishes (60 mm) was based on the method of Sacramento et al. (24) . Nucleic acid extracts were treated with DNase I (0.05 U RI.-'; Promega) for 20 min at 37°C, and the RNA was recovered by extraction with phenol-chloroform (50:50) and then with chloroform and precipitated at -20°C in 0.3 M sodium acetate (pH 5.2) in 2.5 volumes of ethanol. Samples were denatured in 10 mM NaH2PO4-Na2HPO4 (pH 7.4) containing 0.5 mM EDTA and 50% formamide for 5 min at 65°C and then separated by electrophoresis on a 1% (wt/vol) agarose gel containing 10% (vol/vol) formaldehyde. The RNA was transferred onto Hybond-N membranes (Amersham), fixed by exposure to UV irradiation for 5 min, and then heated at 85°C for 2 h. The membranes were prehybridized for 20 min at 65°C in 0.5 M NaH2PO4-Na2HPO4 (pH 7.4) containing 1 mM EDTA and 7% SDS, hybridized with selective probes for 20 h at 65°C, washed in 40 mM NaH2PO4-Na2HPO4 (pH 7.4) containing 1 mM EDTA and 1% SDS (once at 55°C and twice at 65°C for 10 min each time), and exposed to Kodak X-Omat autoradiographic film for 3 to (Fig. lb and c) .
To determine whether the antiviral effect was related to a modification in viral transcription, we determined the levels of rabies virus mRNA transcripts produced in the presence of 1.5 mM ketamine relative to those produced in untreated infected controls. Quantitative analysis of autoradiograms from Northern blots demonstrated that in ketamine-treated cells, the levels of viral N, M2, and G gene transcripts were 5-, 11-, and 6-fold lower, respectively, than equivalent control levels at 48 h p.i. (Fig. 2a) . In contrast, ketamine had no effect on overall cellular transcription, as no decrease in the level of cellular 1-actin mRNA was observed (Fig. 2a) . Similarly, MK-801 reduced rabies virus N mRNA transcription (over 4-fold; Fig. 2b) as well as the levels of viral nucleocapsids and extracellular rabies virus titers (approximately 1,000-fold; data not shown). On the other hand, the general anesthetic chloral hydrate, when used at an identical concentration, caused no significant reduction of any of the above (Fig. 2b and data not shown) .
To quantify as a function of time the inhibition of rabies virus production, we compared the levels of viral protein synthesis in cells treated with ketamine with those in untreated cells during a 72-h incubation period. A progressive increase in the number of viral nucleoprotein inclusions, detected by immunofluorescence microscopy, was observed in control infected cells from 24 to 72 h p.i. (Fig. 3) nucleoproteins from 24 to 72 h p.i. (Fig. 4) . This increase correlated with a twofold increase in the amounts of N gene transcripts (Fig. 5) . Ketamine, on the other hand, considerably reduced the levels of both viral nucleoproteins (two-to threefold) and N gene transcripts (three-to fivefold) relative to those in control infected cells (Fig. 4) 105 cpm ml-') and cellular I8-actin (2.8 x 105 cpm ml-') probes.
Mock-infected controls were uniformly negative. Autoradiograms were developed after 5 to 9 days. 24 h p.i. (Fig. 5) . No taining all five viral proteins, into the culture supernatant (Fig. 6 ). However, with ketamine, no extracellular viral proteins were detected, as in mock-infected cells (Fig. 6) .
The concentration of ketamine (1 to 1.5 mM) used in the present study did not inhibit total cellular protein synthesis, as analyzed by the incorporation of [35S]methionine into trichloroacetic acid-precipitable material, because no significant difference was observed relative to controls (Fig. 7a) . Similarly, cell morphology or viability (Fig. 7b) , as assessed by phase-contrast microscopy or a sensitive histofluorescence staining procedure (15), respectively, was unaffected. These results are further evidence that the inhibition of rabies virus replication with ketamine was not related to any relative inhibition of cellular functions.
DISCUSSION
The present study demonstrated a novel antiviral effect of the general anesthetic ketamine against rabies virus in rat primary cortical neurons; the effect was not a virucidal or cytopathic one. Furthermore, under our conditions of inoculation, it is unlikely that ketamine had any effect on the early events of viral infection of neurons, such as binding, penetration, or uncoating. In addition, the antiviral effect was not related to an inhibition of cellular transcription or translation because (i) the expression of a "housekeeping" gene (p-actin) was unaffected by the drug treatment and (ii) 1753 VOL. 36, 1992 £. the inhibitory effects on viral mRNA and protein syntheses occurred to a similar extent, indicating that viral mRNA was fully translated. This result strongly suggests that the antiviral activity involves an inhibition of rabies virus genome transcription; however, an additional effect on viral genome replication cannot be ruled out. Present-day models of rhabdovirus transcription suggest a sequential decline in viral genome transcription from the 3'-to the 5'-encoded cistrons (3) . On this basis, it is possible that the ketaminemediated inhibition of viral mRNA transcription modifies rabies virus genome transcription by influencing the amounts of rabies virus mRNAs. However, the inhibition is not complete, and a time-dependent recovery in viral transcription and protein synthesis is observed. The mechanism by which this recovery occurs is not known, but it is possible that inactivation of ketamine by ionization and/or metabolism to an N-methylated product (9) parallels the recovery in rabies virus genome transcription. This suggestion is supported by the fact that we observed no increase in extracellular rabies virus titers or the synthesis of viral nucleocapsids when fresh medium containing ketamine (1.5 mM) was added daily for up to 7 days p.i. (34) .
The antiviral mechanism of ketamine appears unrelated to any effect on cellular cytoskeletal organization, because we observed no gross morphological changes in neuronal structure and, furthermore, the disruption of neuronal actin filaments does not affect rabies virus production (19) . Similarly, a ketamine-mediated modification in channel-mediated transmembrane ion flux is unlikely to inhibit viral synthesis because the Na+ and Ca2" channel antagonists amiloride (1 to 25 ,uM) (34) and nifedipine (1 to 10 p,M) (19) , respectively, do not affect rabies virus production.
In a previous study, we demonstrated that MK-801 inhibited rabies virus infection in rat primary cortical neurons (32) . Here we have shown that the antiviral effect involves an inhibition of rabies virus genome transcription similar to that observed with ketamine. However, it is uncertain whether the inhibitory effect is related to the anesthetic or other specific functional properties of these drugs. It was previously shown that high concentrations of local anesthetics possess antiviral activities, but in those cases, the inhibitory effect was likely to have resulted from a drug-induced virucidal effect (39) or an inhibition of cellular protein synthesis (7) . It has been reported that volatile general anesthetics possess antiviral activities, probably by blocking viral RNA synthesis (15, 16) . For example, halothane differentially inhibits the replication of a number of RNA-and DNA-containing viruses (4, 5) . In contrast, in the present study, the general anesthetic chloral hydrate had no effect on rabies virus synthesis; however, the lack of an antiviral effect with chloral hydrate could be due to the fact that it is clinically less potent than ketamine. Furthermore, the antiviral effects of ketamine and MK-801 are virus selective, because the replication of herpes simplex virus, vesicular stomatitis virus, poliovirus type 1, and human immunodeficiency virus type 1 was not inhibited by either anesthetic (32, 34) .
It is well established that general anesthetics can directly interact with membrane proteins and thereby inhibit their function (27) . Furthermore, because noncompetitive NMDA receptor antagonists have no difficulty penetrating the cytoplasm of neurons (13) , ketamine may act on an intracellular target. Specific intracellular proteins, notably, ,B-tubulin (21), or metabolic systems, such as ATP levels (28) , were previously shown to regulate viral transcription. Consequently, the lack of any significant modification in cellular P-actin transcription or total cell protein synthesis with ketamine does not eliminate the possibility that ketamine may have affected a unique cellular protein or metabolic process essential for efficient viral transcription. However, whether the antiviral mechanism of ketamine acts by modifying a cell surface or intracellular target site necessary for rabies virus transcription remains to be elucidated.
After entry into the nervous system, rabies virus is not accessible to the immune response induced by vaccination and immunotherapy because the blood-brain barrier restricts the passage of neutralizing antibodies (22) . We previously showed that peripheral treatment of rabies virus-infected rats with ketamine reduced rabies virus infection in the thalamus, cortex, and hippocampal formation (in particular, the pyramidal layer of the CAl region) (20) . Similarly, a recent report has described a protective effect of the NMDA receptor antagonist MK-801 against measles virus-induced neurodegeneration (1) . Thus, the antiviral activities of ketamine and MK-801, along with their neuroprotective action (23, 25) , could represent an important potential for these drugs in the treatment of advanced clinical rabies.
